Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ampyra for Gait Impairment in Parkinson's Disease
NCT01491022Phase 2Completed
- Sponsor
- University of Miami
- Start
- Jul 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dalfampridine in Parkinson's disease (PD), sponsored by University of Miami. Started Jul 2012; status: completed.
02
Drugs
dalfampridine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01491022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01491022.